Evidence map›Paper›PMID 25887645›Full record

ArticleBMC complementary and alternative medicine2015

Qiwei granules alleviates podocyte lesion in kidney of diabetic KK-Ay mice.

Jingxin Zhou, Wen Sun, Hisae Yoshitomi, Linyi Li, Lingling Qin, Xiangyu Guo, Lili Wu, Yan Zhang, Xinli Wu, Tunhai Xu and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Tangzhiqing Granules Alleviate Podocyte Epithelial-Mesenchymal Transition in Kidney of Diabetic Rats.Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jingxin ZhouBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. zhoujingxin2000@126.com.
Wen SunBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. sunweng00897@163.com.
Hisae YoshitomiSchool of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo, 663-8179, Japan. hisa4403@mukogawa-u.ac.jp.
Linyi LiBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. lilinyi8567@163.com.
Lingling QinBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. qllqxtslx@126.com.
Xiangyu GuoBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. gxyc1003@163.com.
Lili WuBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. qingniao_566@163.com.
Yan ZhangBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. lyla111@126.com.
Xinli WuBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. wuxinli840711@163.com.
Tunhai XuBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. thxu@163.com.
Ming GaoSchool of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo, 663-8179, Japan. gaoming@mukogawa-u.ac.jp.
Tonghua LiuBeijing University of Chinese Medicine, 11 North 3rd-ring East Road, 100029, Chaoyang District, Beijing, People's Republic of China. thliu@vip.163.com.
Beijing University of Chinese Medicine · CNMukogawa Women's University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChinese medicine comprised of all natural herbs is widespread used in the treatment of diabetic nephropathy (DN). Podocyte contributes to the integrity of glomerular filtration barrier whose injury plays an important role in the initiation and progression of DN. Our study aimed to investigate the effect of Qiwei granules on podocyte lesion in diabetic KK-A(y) mice kidney and its underlying mechanism.

methodsTwelve-week-old male KK-A(y) mice were randomly divided in vehicle group and Qiwei granules group, while C57BL/6J mice were used as normal control. The mice were gavage with 1.37 g/kg/day Qiwei granules or water for 10 weeks. We measured water, food intake and body weight (BW) and fasting blood glucose (FBG) every 2 weeks, and urine protein every 4 weeks. At the end of the experiment, all surviving mice were sacrificed. The kidney weight and serum renal parameters were measured, and the renal morphology was observed. To search the underlying mechanism, we examined the podocyte positive marker, slit diaphragm protein expression and some involved cell signal pathway.

resultsQiwei granules treatment significantly improved the metabolic parameters, alleviated the urinary protein, and protected renal function in KK-A(y) mice. In addition, the glomerular injuries and podocyte lesions were mitigated with Qiwei granules treatment. Furthermore, Qiwei granules increased expression of nephrin, CD2AP, and integrin alpha3beta1 in the podocytes of KK-A(y) mice. Qiwei granules improved the phosphoration of Akt and inhibited cleaved caspase-3 protein expression.

conclusionThese finding suggest that Qiwei granules protects the podocyte from the development of DN via improving slit diaphragm (SD) molecules expression and likely activating Akt signaling pathway in KK-A(y) mice.

Indexed as

MagnoliopsidaPhytotherapyAdaptor Proteins, Signal TransducingAnimalsBiomarkersBody WeightCaspase 3Cytoskeletal ProteinsDiabetic NephropathiesDrugs, Chinese HerbalIntegrin alpha3beta1KidneyMaleMembrane ProteinsMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingBiomarkersCaspase 3CD2-associated proteinCytoskeletal ProteinsDrugs, Chinese HerbalIntegrin alpha3beta1Membrane ProteinsnephrinProtective Agents

Identifiers

PMID25887645
PMCPMC4405832
OpenAlexW2091481152

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.